(Q39823756)

English

A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge (English)

1 reference

Europe PubMed Central

14 September 2017

author name string

Haifeng Gao

1

1 reference

Europe PubMed Central

14 September 2017

Yan Yue

2

1 reference

Europe PubMed Central

14 September 2017

Linkun Hu

3

1 reference

Europe PubMed Central

14 September 2017

Wei Xu

4

1 reference

Europe PubMed Central

14 September 2017

Sidong Xiong

5

1 reference

Europe PubMed Central

14 September 2017

language of work or name

0 references

publication date

16 July 2009

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

27

1 reference

Europe PubMed Central

14 September 2017

39

1 reference

Europe PubMed Central

14 September 2017

5313-5319

1 reference

Europe PubMed Central

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Confronting the scientific obstacles to global control of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Characterization of human cellular immune responses to novel Mycobacterium tuberculosis antigens encoded by genomic regions absent in Mycobacterium bovis BCG

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

A New Multi-clade DNA Prime/Recombinant MVA Boost Vaccine Induces Broad and High Levels of HIV-1-specific CD8+ T-cell and Humoral Responses in Mice

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

https://pubmed.ncbi.nlm.nih.gov/19615961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epitope enhancement of a CD4 HIV epitope toward the development of the next generation HIV vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Development of a DNA Vaccine Designed to Induce Cytotoxic T Lymphocyte Responses to Multiple Conserved Epitopes in HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Heat-shock proteins as powerful weapons in vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Recombinant heat shock protein 65 carrying hepatitis B core antigen induces HBcAg-specific CTL response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Successful primate immunization with peptides conjugated to purified protein derivative or mycobacterial heat shock proteins in the absence of adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Mucosally delivered dendritic cells activate T cells independently of IL-12 and endogenous APCs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Tuberculosis vaccine development: goals, immunological design, and evaluation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Tuberculosis: from genome to vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Current status of TB vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Evaluation of the immunogenicity of pBudCE4.1 plasmids encoding mycolyl-transferase Ag85A and phosphate transport receptor PstS-3 from Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Improved tuberculosis DNA vaccines by formulation in cationic lipids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Expression and immunogenicity of Mycobacterium tuberculosis antigen 85 by DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Interferon gamma, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.093

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.06.093

1 reference

Europe PubMed Central

14 September 2017

0 references

1 reference

Europe PubMed Central

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39823756&oldid=2090957152"